<?xml-stylesheet type="text/xsl" href="varreports_v3.xsl"?><data_table name="vr_cancer_2013_a_0018s" dataset_id="pht000039.v12" study_name="Framingham Cohort" study_id="phs000007.v30" participant_set="11" date_created="2018/09/17"><description>Cancer, Original, Offspring, Generation 3, New Offspring Spouse, Omni 1, and Omni 2 (all cohorts) through September 2013. The goal of this dataset is to 1) identify, confirm and code all malignancies appearing among participants of every generation of the Framingham Heart Study, 2) describe relationships between already identified FHS risk factors and the development of malignancies among participants, and 3) describe interactions among risk factors, CVD, and cancer in the FHS population(s). Included are the codes for all FHS reviewed cases of primary cancers (malignant or in-situ), that have been verified by pathology reports, or occasionally by other clinical records, for all Framingham Heart Study participants in all cohorts who reported a tumor or cancer at an examination or on a health history survey. Excluded are cases described in pathology reports as benign tumors or tumors of borderline malignancy, or cases described as metastases from other primary cancers. Also excluded are recurrences of basal cell and squamous cell skin cancers; the first occurrence of each of these series is the only one included for any individual person.</description><variable id="phv00010777.v11.p11" var_name="shareid" calculated_type="string" reported_type=""><description>Unique study participant identification number</description><total><subject_profile><sex><male>1996</male><female>2142</female></sex></subject_profile><stats><stat n="5334" nulls="0"/></stats></total></variable><variable id="phv00010777.v11.p11.c1" var_name="shareid" calculated_type="string" reported_type=""><description>Unique study participant identification number</description><total><subject_profile><sex><male>1680</male><female>1801</female></sex></subject_profile><stats><stat n="4426" nulls="0"/></stats></total></variable><variable id="phv00010777.v11.p11.c2" var_name="shareid" calculated_type="string" reported_type=""><description>Unique study participant identification number</description><total><subject_profile><sex><male>313</male><female>339</female></sex></subject_profile><stats><stat n="900" nulls="0"/></stats></total></variable><variable id="phv00010767.v11.p11" var_name="IDTYPE" calculated_type="enum_integer" reported_type=""><description>Framingham Heart Study cohort identifier</description><total><subject_profile><sex><male>1996</male><female>2142</female></sex></subject_profile><stats><stat n="5334" nulls="0" mean_count="889" sd="1186" median_count="226.5" min_count="21" max_count="2441"/><enum code="1" count="2441">Offspring Cohort</enum><enum code="0" count="2379">Original Cohort</enum><enum code="3" count="389">Generation 3 Cohort</enum><enum code="7" count="64">Omni 1 Cohort</enum><enum code="2" count="40">New Offspring Spouse Cohort</enum><enum code="72" count="21">Omni 2 Cohort</enum></stats></total></variable><variable id="phv00010767.v11.p11.c1" var_name="IDTYPE" calculated_type="enum_integer" reported_type=""><description>Framingham Heart Study cohort identifier</description><total><subject_profile><sex><male>1680</male><female>1801</female></sex></subject_profile><stats><stat n="4426" nulls="0" mean_count="737.7" sd="973.1" median_count="207.5" min_count="18" max_count="2107"/><enum code="0" count="2107">Original Cohort</enum><enum code="1" count="1848">Offspring Cohort</enum><enum code="3" count="376">Generation 3 Cohort</enum><enum code="7" count="39">Omni 1 Cohort</enum><enum code="2" count="38">New Offspring Spouse Cohort</enum><enum code="72" count="18">Omni 2 Cohort</enum></stats></total></variable><variable id="phv00010767.v11.p11.c2" var_name="IDTYPE" calculated_type="enum_integer" reported_type=""><description>Framingham Heart Study cohort identifier</description><total><subject_profile><sex><male>313</male><female>339</female></sex></subject_profile><stats><stat n="900" nulls="0" mean_count="150" sd="237.5" median_count="19" min_count="2" max_count="585"/><enum code="1" count="585">Offspring Cohort</enum><enum code="0" count="272">Original Cohort</enum><enum code="7" count="25">Omni 1 Cohort</enum><enum code="3" count="13">Generation 3 Cohort</enum><enum code="72" count="3">Omni 2 Cohort</enum><enum code="2" count="2">New Offspring Spouse Cohort</enum></stats></total></variable><variable id="phv00010768.v11.p11" var_name="DIAG_TYP" calculated_type="enum_integer" reported_type=""><description>Method of diagnosis - represents the basis of diagnosis</description><total><subject_profile><sex><male>1996</male><female>2142</female></sex></subject_profile><stats><stat n="5334" nulls="0" mean_count="1778" sd="2934" median_count="162" min_count="7" max_count="5165"/><enum code="1" count="5165">Microscopically confirmed</enum><enum code="2" count="162">Clinically diagnosed</enum><enum code="3" count="7">Death certificate only</enum></stats></total></variable><variable id="phv00010768.v11.p11.c1" var_name="DIAG_TYP" calculated_type="enum_integer" reported_type=""><description>Method of diagnosis - represents the basis of diagnosis</description><total><subject_profile><sex><male>1680</male><female>1801</female></sex></subject_profile><stats><stat n="4426" nulls="0" mean_count="1475" sd="2432" median_count="137" min_count="7" max_count="4282"/><enum code="1" count="4282">Microscopically confirmed</enum><enum code="2" count="137">Clinically diagnosed</enum><enum code="3" count="7">Death certificate only</enum></stats></total></variable><variable id="phv00010768.v11.p11.c2" var_name="DIAG_TYP" calculated_type="enum_integer" reported_type=""><description>Method of diagnosis - represents the basis of diagnosis</description><total><subject_profile><sex><male>313</male><female>339</female></sex></subject_profile><stats><stat n="900" nulls="0" mean_count="450" sd="602.5" median_count="450" min_count="24" max_count="876"/><enum code="1" count="876">Microscopically confirmed</enum><enum code="2" count="24">Clinically diagnosed</enum></stats></total></variable><variable id="phv00010769.v11.p11" var_name="EXACT" calculated_type="enum_integer" reported_type=""><description>Type of Date - diagnosis date qualifier - indicates the quality of D_DATE</description><total><subject_profile><sex><male>1996</male><female>2142</female></sex></subject_profile><stats><stat n="5334" nulls="0" mean_count="2667" sd="3321" median_count="2667" min_count="319" max_count="5015"/><enum code="0" count="5015">Month, date and year of diagnosis date taken from pathology report or other test report.</enum><enum code="1" count="319">Estimated diagnosis date as described in variable D_DATE</enum></stats></total></variable><variable id="phv00010769.v11.p11.c1" var_name="EXACT" calculated_type="enum_integer" reported_type=""><description>Type of Date - diagnosis date qualifier - indicates the quality of D_DATE</description><total><subject_profile><sex><male>1680</male><female>1801</female></sex></subject_profile><stats><stat n="4426" nulls="0" mean_count="2213" sd="2766" median_count="2213" min_count="257" max_count="4169"/><enum code="0" count="4169">Month, date and year of diagnosis date taken from pathology report or other test report.</enum><enum code="1" count="257">Estimated diagnosis date as described in variable D_DATE</enum></stats></total></variable><variable id="phv00010769.v11.p11.c2" var_name="EXACT" calculated_type="enum_integer" reported_type=""><description>Type of Date - diagnosis date qualifier - indicates the quality of D_DATE</description><total><subject_profile><sex><male>313</male><female>339</female></sex></subject_profile><stats><stat n="900" nulls="0" mean_count="450" sd="551.5" median_count="450" min_count="60" max_count="840"/><enum code="0" count="840">Month, date and year of diagnosis date taken from pathology report or other test report.</enum><enum code="1" count="60">Estimated diagnosis date as described in variable D_DATE</enum></stats></total></variable><variable id="phv00010770.v11.p11" var_name="TOPO" calculated_type="enum_integer" reported_type=""><description>Topography - describes site - corresponds to first three digits of topography code WHO ICD-O</description><comment>TOPO modified - cancer site categories with less than five cases were recategorized under "other" to preserve participant confidentiality.</comment><total><subject_profile><sex><male>1996</male><female>2142</female></sex></subject_profile><stats><stat n="5334" nulls="0" mean_count="127" sd="290.6" median_count="22.5" min_count="5" max_count="1725"/><example code="173" count="1725">Skin (excludes skin of labia majora, skin of vulva, skin of penis and skin of scrotum)</example><example code="174" count="648">Female breast (excludes skin of breast)</example><example code="185" count="479">Prostate gland</example><example code="162" count="455">Trachea bronchus, and lung</example><example code="153" count="368">Colon</example><example code="188" count="213">Urinary bladder</example><example code="169" count="187">Hematopoietic and reticuloendothelial systems</example><example code="154" count="139">Rectum, rectosigmoid junction, anal canal and anus, not otherwise specified</example><example code="196" count="105">Lymph nodes</example><example code="182" count="99">Corpus uteri or endometrium</example></stats></total></variable><variable id="phv00010770.v11.p11.c1" var_name="TOPO" calculated_type="enum_integer" reported_type=""><description>Topography - describes site - corresponds to first three digits of topography code WHO ICD-O</description><comment>TOPO modified - cancer site categories with less than five cases were recategorized under "other" to preserve participant confidentiality.</comment><total><subject_profile><sex><male>1680</male><female>1801</female></sex></subject_profile><stats><stat n="4426" nulls="0" mean_count="105.4" sd="234.5" median_count="20" min_count="5" max_count="1382"/><example code="173" count="1382">Skin (excludes skin of labia majora, skin of vulva, skin of penis and skin of scrotum)</example><example code="174" count="528">Female breast (excludes skin of breast)</example><example code="185" count="396">Prostate gland</example><example code="162" count="386">Trachea bronchus, and lung</example><example code="153" count="318">Colon</example><example code="188" count="177">Urinary bladder</example><example code="169" count="161">Hematopoietic and reticuloendothelial systems</example><example code="154" count="124">Rectum, rectosigmoid junction, anal canal and anus, not otherwise specified</example><example code="151" count="90">Stomach</example><example code="182" count="83">Corpus uteri or endometrium</example></stats></total></variable><variable id="phv00010770.v11.p11.c2" var_name="TOPO" calculated_type="enum_integer" reported_type=""><description>Topography - describes site - corresponds to first three digits of topography code WHO ICD-O</description><comment>TOPO modified - cancer site categories with less than five cases were recategorized under "other" to preserve participant confidentiality.</comment><total><subject_profile><sex><male>313</male><female>339</female></sex></subject_profile><stats><stat n="900" nulls="0" mean_count="24.32" sd="58.93" median_count="6" min_count="1" max_count="339"/><example code="173" count="339">Skin (excludes skin of labia majora, skin of vulva, skin of penis and skin of scrotum)</example><example code="174" count="119">Female breast (excludes skin of breast)</example><example code="185" count="81">Prostate gland</example><example code="162" count="69">Trachea bronchus, and lung</example><example code="153" count="50">Colon</example><example code="188" count="36">Urinary bladder</example><example code="169" count="26">Hematopoietic and reticuloendothelial systems</example><example code="196" count="23">Lymph nodes</example><example code="182" count="16">Corpus uteri or endometrium</example><example code="154" count="15">Rectum, rectosigmoid junction, anal canal and anus, not otherwise specified</example></stats></total></variable><variable id="phv00010771.v11.p11" var_name="LOCATION" calculated_type="integer" reported_type=""><description>Location - describes subdivision of site - corresponds to fourth digit of topography code WHO ICD-O</description><total><subject_profile><sex><male>1996</male><female>2142</female></sex></subject_profile><stats><stat n="5334" nulls="0" mean="4.5" sd="3.021" median="4" min="0" max="9"/><enum count="1111">3</enum><enum count="1062">9</enum><enum count="574">0</enum><enum count="521">4</enum><enum count="496">5</enum><enum count="460">1</enum><enum count="348">6</enum><enum count="321">2</enum><enum count="270">8</enum><enum count="171">7</enum></stats></total></variable><variable id="phv00010771.v11.p11.c1" var_name="LOCATION" calculated_type="integer" reported_type=""><description>Location - describes subdivision of site - corresponds to fourth digit of topography code WHO ICD-O</description><total><subject_profile><sex><male>1680</male><female>1801</female></sex></subject_profile><stats><stat n="4426" nulls="0" mean="4.528" sd="3.041" median="4" min="0" max="9"/><enum count="917">3</enum><enum count="917">9</enum><enum count="471">0</enum><enum count="430">4</enum><enum count="408">5</enum><enum count="391">1</enum><enum count="287">6</enum><enum count="258">2</enum><enum count="220">8</enum><enum count="127">7</enum></stats></total></variable><variable id="phv00010771.v11.p11.c2" var_name="LOCATION" calculated_type="integer" reported_type=""><description>Location - describes subdivision of site - corresponds to fourth digit of topography code WHO ICD-O</description><total><subject_profile><sex><male>313</male><female>339</female></sex></subject_profile><stats><stat n="900" nulls="0" mean="4.354" sd="2.921" median="4" min="0" max="9"/><enum count="194">3</enum><enum count="143">9</enum><enum count="102">0</enum><enum count="89">4</enum><enum count="88">5</enum><enum count="69">1</enum><enum count="62">2</enum><enum count="60">6</enum><enum count="50">8</enum><enum count="43">7</enum></stats></total></variable><variable id="phv00010772.v11.p11" var_name="HIST" calculated_type="integer" reported_type=""><description>Histology or morphology - describes cell histopathology - corresponds to four digit morphology code WHO ICD-O</description><comment>Additional morphology codes from the ICD-O-3 code book are added to the FHS cancer coding system:     8046 - Non-small cell carcinoma;     8077 - Squamous intraepithelial neoplasia,                  Cervical intraepithelial neoplasia,                  Vaginal intraepithelial neoplasia,                  Vulvar intraepithelial neoplasia,                  Anal intraepithelial neoplasia;     8130 - Papillary transitional cell carcinoma;     8148 - Glandular intraepithelial neoplasia,                   Prostatic intraepithelial neoplasia;     8162 - Klatskin tumor;     8253 - Bronchiolo-alveolar carcinoma, mucinous;     8255 - Adenocarcinoma with mixed subtypes;     8317 - Renal cell carcinoma, chromophobe type;     8522 - Intraductal carcinoma and lobular carcinoma in situ;     8858 - Dedifferentiated liposarcoma;     9590-9769 - Hodgkin's and non-Hodgkin lymphomas;     9590-9596 - Malignant lymphomas, NOS or diffuse;     9650-9667 - Hodgkin's lymphoma;     9670-9729 - Non-Hodgkin's lymphomas;     9670-9699 - Mature B-cell lymphomas;              9673 - Mantle cell lymphoma;              9680 - Malignant lymphoma, large B-cell, diffuse or malignant                         lymphoma, large cell;     9700-9719 - Mature T-cell and NK-cell lymphomas;     9727-9729 - Precursor cell lymohoblastic lymphomas;     9731-9734 - Plasma cell tumors;     9740-9742 - Mast cell tumors;     9750-9758 - Neoplasms of histiocytes and accessory lymphoid cells;     9760-9769 - Immunoproliferative diseases;     9872 - Acute myeloid leukemia, minimal differentiation;     9895 - Acute myeloid leukemia with multilineage dysplasia;     9987 - Therapy related myelodysplastic syndrome;     9989 - Myelodysplastic syndrome, NOS</comment><total><subject_profile><sex><male>1996</male><female>2142</female></sex></subject_profile><stats><stat n="5334" nulls="0" mean="8321" sd="447.2" median="8140" min="8000" max="9990"/><example count="1157">8140</example><example count="936">8090</example><example count="690">8070</example><example count="393">8500</example><example count="150">8010</example><example count="139">8130</example><example count="93">8720</example><example count="89">8480</example><example count="76">8120</example><example count="67">8520</example></stats></total></variable><variable id="phv00010772.v11.p11.c1" var_name="HIST" calculated_type="integer" reported_type=""><description>Histology or morphology - describes cell histopathology - corresponds to four digit morphology code WHO ICD-O</description><comment>Additional morphology codes from the ICD-O-3 code book are added to the FHS cancer coding system:     8046 - Non-small cell carcinoma;     8077 - Squamous intraepithelial neoplasia,                  Cervical intraepithelial neoplasia,                  Vaginal intraepithelial neoplasia,                  Vulvar intraepithelial neoplasia,                  Anal intraepithelial neoplasia;     8130 - Papillary transitional cell carcinoma;     8148 - Glandular intraepithelial neoplasia,                   Prostatic intraepithelial neoplasia;     8162 - Klatskin tumor;     8253 - Bronchiolo-alveolar carcinoma, mucinous;     8255 - Adenocarcinoma with mixed subtypes;     8317 - Renal cell carcinoma, chromophobe type;     8522 - Intraductal carcinoma and lobular carcinoma in situ;     8858 - Dedifferentiated liposarcoma;     9590-9769 - Hodgkin's and non-Hodgkin lymphomas;     9590-9596 - Malignant lymphomas, NOS or diffuse;     9650-9667 - Hodgkin's lymphoma;     9670-9729 - Non-Hodgkin's lymphomas;     9670-9699 - Mature B-cell lymphomas;              9673 - Mantle cell lymphoma;              9680 - Malignant lymphoma, large B-cell, diffuse or malignant                         lymphoma, large cell;     9700-9719 - Mature T-cell and NK-cell lymphomas;     9727-9729 - Precursor cell lymohoblastic lymphomas;     9731-9734 - Plasma cell tumors;     9740-9742 - Mast cell tumors;     9750-9758 - Neoplasms of histiocytes and accessory lymphoid cells;     9760-9769 - Immunoproliferative diseases;     9872 - Acute myeloid leukemia, minimal differentiation;     9895 - Acute myeloid leukemia with multilineage dysplasia;     9987 - Therapy related myelodysplastic syndrome;     9989 - Myelodysplastic syndrome, NOS</comment><total><subject_profile><sex><male>1680</male><female>1801</female></sex></subject_profile><stats><stat n="4426" nulls="0" mean="8323" sd="451.4" median="8140" min="8000" max="9990"/><example count="974">8140</example><example count="759">8090</example><example count="568">8070</example><example count="321">8500</example><example count="127">8010</example><example count="113">8130</example><example count="80">8720</example><example count="76">8480</example><example count="63">8120</example><example count="52">8000</example></stats></total></variable><variable id="phv00010772.v11.p11.c2" var_name="HIST" calculated_type="integer" reported_type=""><description>Histology or morphology - describes cell histopathology - corresponds to four digit morphology code WHO ICD-O</description><comment>Additional morphology codes from the ICD-O-3 code book are added to the FHS cancer coding system:     8046 - Non-small cell carcinoma;     8077 - Squamous intraepithelial neoplasia,                  Cervical intraepithelial neoplasia,                  Vaginal intraepithelial neoplasia,                  Vulvar intraepithelial neoplasia,                  Anal intraepithelial neoplasia;     8130 - Papillary transitional cell carcinoma;     8148 - Glandular intraepithelial neoplasia,                   Prostatic intraepithelial neoplasia;     8162 - Klatskin tumor;     8253 - Bronchiolo-alveolar carcinoma, mucinous;     8255 - Adenocarcinoma with mixed subtypes;     8317 - Renal cell carcinoma, chromophobe type;     8522 - Intraductal carcinoma and lobular carcinoma in situ;     8858 - Dedifferentiated liposarcoma;     9590-9769 - Hodgkin's and non-Hodgkin lymphomas;     9590-9596 - Malignant lymphomas, NOS or diffuse;     9650-9667 - Hodgkin's lymphoma;     9670-9729 - Non-Hodgkin's lymphomas;     9670-9699 - Mature B-cell lymphomas;              9673 - Mantle cell lymphoma;              9680 - Malignant lymphoma, large B-cell, diffuse or malignant                         lymphoma, large cell;     9700-9719 - Mature T-cell and NK-cell lymphomas;     9727-9729 - Precursor cell lymohoblastic lymphomas;     9731-9734 - Plasma cell tumors;     9740-9742 - Mast cell tumors;     9750-9758 - Neoplasms of histiocytes and accessory lymphoid cells;     9760-9769 - Immunoproliferative diseases;     9872 - Acute myeloid leukemia, minimal differentiation;     9895 - Acute myeloid leukemia with multilineage dysplasia;     9987 - Therapy related myelodysplastic syndrome;     9989 - Myelodysplastic syndrome, NOS</comment><total><subject_profile><sex><male>313</male><female>339</female></sex></subject_profile><stats><stat n="900" nulls="0" mean="8309" sd="427.5" median="8140" min="8000" max="9990"/><example count="181">8140</example><example count="175">8090</example><example count="121">8070</example><example count="71">8500</example><example count="26">8130</example><example count="23">8010</example><example count="18">8081</example><example count="16">8520</example><example count="13">8120</example><example count="13">8480</example></stats></total></variable><variable id="phv00010773.v11.p11" var_name="BEHAVIOR" calculated_type="enum_integer" reported_type=""><description>Behavior - decribes the degree of malignancy - corresponds to the fifth digit behavior code WHO ICD-O</description><comment>This set contains only cases where BEHAVIOR = 2 or BEHAVIOR = 3. Metastatic code (BEHAVIOR = 6) was not used; rather the location of the primary site was used. If the primary site is unknown, the code 199 is used for the site.</comment><total><subject_profile><sex><male>1996</male><female>2142</female></sex></subject_profile><stats><stat n="5334" nulls="0" mean_count="2667" sd="3172" median_count="2667" min_count="424" max_count="4910"/><enum code="3" count="4910">Malignant, primary site</enum><enum code="2" count="424">Carcinoma in situ, non-invasive</enum></stats></total></variable><variable id="phv00010773.v11.p11.c1" var_name="BEHAVIOR" calculated_type="enum_integer" reported_type=""><description>Behavior - decribes the degree of malignancy - corresponds to the fifth digit behavior code WHO ICD-O</description><comment>This set contains only cases where BEHAVIOR = 2 or BEHAVIOR = 3. Metastatic code (BEHAVIOR = 6) was not used; rather the location of the primary site was used. If the primary site is unknown, the code 199 is used for the site.</comment><total><subject_profile><sex><male>1680</male><female>1801</female></sex></subject_profile><stats><stat n="4426" nulls="0" mean_count="2213" sd="2643" median_count="2213" min_count="344" max_count="4082"/><enum code="3" count="4082">Malignant, primary site</enum><enum code="2" count="344">Carcinoma in situ, non-invasive</enum></stats></total></variable><variable id="phv00010773.v11.p11.c2" var_name="BEHAVIOR" calculated_type="enum_integer" reported_type=""><description>Behavior - decribes the degree of malignancy - corresponds to the fifth digit behavior code WHO ICD-O</description><comment>This set contains only cases where BEHAVIOR = 2 or BEHAVIOR = 3. Metastatic code (BEHAVIOR = 6) was not used; rather the location of the primary site was used. If the primary site is unknown, the code 199 is used for the site.</comment><total><subject_profile><sex><male>313</male><female>339</female></sex></subject_profile><stats><stat n="900" nulls="0" mean_count="450" sd="523.3" median_count="450" min_count="80" max_count="820"/><enum code="3" count="820">Malignant, primary site</enum><enum code="2" count="80">Carcinoma in situ, non-invasive</enum></stats></total></variable><variable id="phv00010774.v11.p11" var_name="GRADE" calculated_type="enum_integer" reported_type=""><description>Grade - correspnds to code for histologic grading and differentiation WHO ICD-O</description><total><subject_profile><sex><male>1996</male><female>2142</female></sex></subject_profile><stats><stat n="5334" nulls="0" mean_count="1067" sd="1124" median_count="706" min_count="237" max_count="3033"/><enum code="9" count="3033">Grade or differentiation not determined, stated, or applicable</enum><enum code="3" count="865">Grade III - poorly differentiated</enum><enum code="2" count="706">Grade II - moderately well-differentiated, moderately differentiated</enum><enum code="1" count="493">Grade I - well-differentiated, differentiated</enum><enum code="4" count="237">Grade IV - undifferentiated, anaplastic</enum></stats></total></variable><variable id="phv00010774.v11.p11.c1" var_name="GRADE" calculated_type="enum_integer" reported_type=""><description>Grade - correspnds to code for histologic grading and differentiation WHO ICD-O</description><total><subject_profile><sex><male>1680</male><female>1801</female></sex></subject_profile><stats><stat n="4426" nulls="0" mean_count="885.2" sd="946" median_count="553" min_count="214" max_count="2543"/><enum code="9" count="2543">Grade or differentiation not determined, stated, or applicable</enum><enum code="3" count="726">Grade III - poorly differentiated</enum><enum code="2" count="553">Grade II - moderately well-differentiated, moderately differentiated</enum><enum code="1" count="390">Grade I - well-differentiated, differentiated</enum><enum code="4" count="214">Grade IV - undifferentiated, anaplastic</enum></stats></total></variable><variable id="phv00010774.v11.p11.c2" var_name="GRADE" calculated_type="enum_integer" reported_type=""><description>Grade - correspnds to code for histologic grading and differentiation WHO ICD-O</description><total><subject_profile><sex><male>313</male><female>339</female></sex></subject_profile><stats><stat n="900" nulls="0" mean_count="180" sd="177.7" median_count="137" min_count="23" max_count="485"/><enum code="9" count="485">Grade or differentiation not determined, stated, or applicable</enum><enum code="2" count="153">Grade II - moderately well-differentiated, moderately differentiated</enum><enum code="3" count="137">Grade III - poorly differentiated</enum><enum code="1" count="102">Grade I - well-differentiated, differentiated</enum><enum code="4" count="23">Grade IV - undifferentiated, anaplastic</enum></stats></total></variable><variable id="phv00080773.v8.p11" var_name="ESTRGN" calculated_type="enum_integer" reported_type=""><description>Estrogen receptors</description><comment>This variable was added to the data collection form in version 10-01-07.</comment><total><subject_profile><sex><female>381</female></sex></subject_profile><stats><stat n="419" nulls="4915" mean_count="104.8" sd="98.69" median_count="89" min_count="9" max_count="232"/><enum code="2" count="232">Positive</enum><enum code="8" count="130">Not done</enum><enum code="0" count="48">Negative</enum><enum code="1" count="9">Weakly positive</enum></stats></total></variable><variable id="phv00080773.v8.p11.c1" var_name="ESTRGN" calculated_type="enum_integer" reported_type=""><description>Estrogen receptors</description><comment>This variable was added to the data collection form in version 10-01-07.</comment><total><subject_profile><sex><female>299</female></sex></subject_profile><stats><stat n="331" nulls="4095" mean_count="82.75" sd="77.5" median_count="72" min_count="7" max_count="180"/><enum code="2" count="180">Positive</enum><enum code="8" count="108">Not done</enum><enum code="0" count="36">Negative</enum><enum code="1" count="7">Weakly positive</enum></stats></total></variable><variable id="phv00080773.v8.p11.c2" var_name="ESTRGN" calculated_type="enum_integer" reported_type=""><description>Estrogen receptors</description><comment>This variable was added to the data collection form in version 10-01-07.</comment><total><subject_profile><sex><female>81</female></sex></subject_profile><stats><stat n="87" nulls="813" mean_count="21.75" sd="21.14" median_count="17" min_count="2" max_count="51"/><enum code="2" count="51">Positive</enum><enum code="8" count="22">Not done</enum><enum code="0" count="12">Negative</enum><enum code="1" count="2">Weakly positive</enum></stats></total></variable><variable id="phv00080774.v8.p11" var_name="PRGSTRN" calculated_type="enum_integer" reported_type=""><description>Progesterone receptors</description><comment>This variable was added to the data collection form in version 10-01-07.</comment><total><subject_profile><sex><female>379</female></sex></subject_profile><stats><stat n="417" nulls="4917" mean_count="104.3" sd="74.03" median_count="104.5" min_count="21" max_count="187"/><enum code="2" count="187">Positive</enum><enum code="8" count="141">Not done</enum><enum code="0" count="68">Negative</enum><enum code="1" count="21">Weakly positive</enum></stats></total></variable><variable id="phv00080774.v8.p11.c1" var_name="PRGSTRN" calculated_type="enum_integer" reported_type=""><description>Progesterone receptors</description><comment>This variable was added to the data collection form in version 10-01-07.</comment><total><subject_profile><sex><female>297</female></sex></subject_profile><stats><stat n="329" nulls="4097" mean_count="82.25" sd="58.49" median_count="83" min_count="19" max_count="144"/><enum code="2" count="144">Positive</enum><enum code="8" count="118">Not done</enum><enum code="0" count="48">Negative</enum><enum code="1" count="19">Weakly positive</enum></stats></total></variable><variable id="phv00080774.v8.p11.c2" var_name="PRGSTRN" calculated_type="enum_integer" reported_type=""><description>Progesterone receptors</description><comment>This variable was added to the data collection form in version 10-01-07.</comment><total><subject_profile><sex><female>81</female></sex></subject_profile><stats><stat n="87" nulls="813" mean_count="21.75" sd="16.38" median_count="21.5" min_count="2" max_count="42"/><enum code="2" count="42">Positive</enum><enum code="8" count="23">Not done</enum><enum code="0" count="20">Negative</enum><enum code="1" count="2">Weakly positive</enum></stats></total></variable><variable id="phv00080775.v8.p11" var_name="H2NI" calculated_type="enum_integer" reported_type=""><description>HER2NEU (human epidermal growth factor receptor 2) by IHC (immunohistochemistry)</description><comment>This variable was added to the data collection form in version 10-01-07.</comment><total><subject_profile><sex><female>433</female></sex></subject_profile><stats><stat n="483" nulls="4851" mean_count="120.8" sd="143.5" median_count="77" min_count="11" max_count="318"/><enum code="8" count="318">Not done</enum><enum code="0" count="136">Negative, 0 or 1+</enum><enum code="2" count="18">Positive, 3+</enum><enum code="1" count="11">Weakly positive, 2+</enum></stats></total></variable><variable id="phv00080775.v8.p11.c1" var_name="H2NI" calculated_type="enum_integer" reported_type=""><description>HER2NEU (human epidermal growth factor receptor 2) by IHC (immunohistochemistry)</description><comment>This variable was added to the data collection form in version 10-01-07.</comment><total><subject_profile><sex><female>338</female></sex></subject_profile><stats><stat n="380" nulls="4046" mean_count="95" sd="115.1" median_count="56.5" min_count="10" max_count="257"/><enum code="8" count="257">Not done</enum><enum code="0" count="97">Negative, 0 or 1+</enum><enum code="2" count="16">Positive, 3+</enum><enum code="1" count="10">Weakly positive, 2+</enum></stats></total></variable><variable id="phv00080775.v8.p11.c2" var_name="H2NI" calculated_type="enum_integer" reported_type=""><description>HER2NEU (human epidermal growth factor receptor 2) by IHC (immunohistochemistry)</description><comment>This variable was added to the data collection form in version 10-01-07.</comment><total><subject_profile><sex><female>94</female></sex></subject_profile><stats><stat n="102" nulls="798" mean_count="25.5" sd="29.01" median_count="20.5" min_count="1" max_count="60"/><enum code="8" count="60">Not done</enum><enum code="0" count="39">Negative, 0 or 1+</enum><enum code="2" count="2">Positive, 3+</enum><enum code="1" count="1">Weakly positive, 2+</enum></stats></total></variable><variable id="phv00080776.v8.p11" var_name="H2NF" calculated_type="enum_integer" reported_type=""><description>HER2NEU (human epidermal growth factor receptor 2) by FISH (fluorescence in situ hybridization)</description><comment>This variable was added to the data collection form in version 10-01-07.</comment><total><subject_profile><sex><female>433</female></sex></subject_profile><stats><stat n="483" nulls="4851" mean_count="161" sd="244.7" median_count="35" min_count="5" max_count="443"/><enum code="8" count="443">Not done</enum><enum code="0" count="35">Unamplified</enum><enum code="1" count="5">Amplified by FISH</enum></stats></total></variable><variable id="phv00080776.v8.p11.c1" var_name="H2NF" calculated_type="enum_integer" reported_type=""><description>HER2NEU (human epidermal growth factor receptor 2) by FISH (fluorescence in situ hybridization)</description><comment>This variable was added to the data collection form in version 10-01-07.</comment><total><subject_profile><sex><female>338</female></sex></subject_profile><stats><stat n="380" nulls="4046" mean_count="126.7" sd="193.8" median_count="27" min_count="3" max_count="350"/><enum code="8" count="350">Not done</enum><enum code="0" count="27">Unamplified</enum><enum code="1" count="3">Amplified by FISH</enum></stats></total></variable><variable id="phv00080776.v8.p11.c2" var_name="H2NF" calculated_type="enum_integer" reported_type=""><description>HER2NEU (human epidermal growth factor receptor 2) by FISH (fluorescence in situ hybridization)</description><comment>This variable was added to the data collection form in version 10-01-07.</comment><total><subject_profile><sex><female>94</female></sex></subject_profile><stats><stat n="102" nulls="798" mean_count="34" sd="51.16" median_count="7" min_count="2" max_count="93"/><enum code="8" count="93">Not done</enum><enum code="0" count="7">Unamplified</enum><enum code="1" count="2">Amplified by FISH</enum></stats></total></variable><variable id="phv00080777.v8.p11" var_name="TISSUE_1" calculated_type="integer" reported_type=""><description>Tissue #1 related to Gleason score for prostate cancer</description><comment>Classifying prostate cancer cells in terms of how abnormal they appear when examined under a microscope. Grades range from 1 to 5 with 1 being the lease aggressive and 5 the most aggressive.
		This variable was added to the data collection form in version 10-01-07. </comment><total><subject_profile><sex><male>275</male></sex></subject_profile><stats><stat n="276" nulls="5058" mean="3.091" sd="0.6681" median="3" min="1" max="5"/><enum count="190">3</enum><enum count="48">4</enum><enum count="25">2</enum><enum count="7">5</enum><enum count="6">1</enum></stats></total></variable><variable id="phv00080777.v8.p11.c1" var_name="TISSUE_1" calculated_type="integer" reported_type=""><description>Tissue #1 related to Gleason score for prostate cancer</description><comment>Classifying prostate cancer cells in terms of how abnormal they appear when examined under a microscope. Grades range from 1 to 5 with 1 being the lease aggressive and 5 the most aggressive.
		This variable was added to the data collection form in version 10-01-07. </comment><total><subject_profile><sex><male>216</male></sex></subject_profile><stats><stat n="216" nulls="4210" mean="3.088" sd="0.6589" median="3" min="1" max="5"/><enum count="154">3</enum><enum count="36">4</enum><enum count="15">2</enum><enum count="6">1</enum><enum count="5">5</enum></stats></total></variable><variable id="phv00080777.v8.p11.c2" var_name="TISSUE_1" calculated_type="integer" reported_type=""><description>Tissue #1 related to Gleason score for prostate cancer</description><comment>Classifying prostate cancer cells in terms of how abnormal they appear when examined under a microscope. Grades range from 1 to 5 with 1 being the lease aggressive and 5 the most aggressive.
		This variable was added to the data collection form in version 10-01-07. </comment><total><subject_profile><sex><male>57</male></sex></subject_profile><stats><stat n="58" nulls="842" mean="3.086" sd="0.708" median="3" min="2" max="5"/><enum count="35">3</enum><enum count="11">4</enum><enum count="10">2</enum><enum count="2">5</enum></stats></total></variable><variable id="phv00080778.v8.p11" var_name="TISSUE_2" calculated_type="integer" reported_type=""><description>Tissue #2 related to Gleason score for prostate cancer</description><comment>Classifying prostate cancer cells in terms of how abnormal they appear when examined under a microscope. Grades range from 1 to 5 with 1 being the lease aggressive and 5 the most aggressive.
		This variable was added to the data collection form in version 10-01-07. </comment><total><subject_profile><sex><male>263</male></sex></subject_profile><stats><stat n="264" nulls="5070" mean="3.379" sd="0.7655" median="3" min="1" max="5"/><enum count="147">3</enum><enum count="79">4</enum><enum count="21">5</enum><enum count="13">2</enum><enum count="4">1</enum></stats></total></variable><variable id="phv00080778.v8.p11.c1" var_name="TISSUE_2" calculated_type="integer" reported_type=""><description>Tissue #2 related to Gleason score for prostate cancer</description><comment>Classifying prostate cancer cells in terms of how abnormal they appear when examined under a microscope. Grades range from 1 to 5 with 1 being the lease aggressive and 5 the most aggressive.
		This variable was added to the data collection form in version 10-01-07. </comment><total><subject_profile><sex><male>206</male></sex></subject_profile><stats><stat n="206" nulls="4220" mean="3.398" sd="0.763" median="3" min="1" max="5"/><enum count="114">3</enum><enum count="63">4</enum><enum count="17">5</enum><enum count="9">2</enum><enum count="3">1</enum></stats></total></variable><variable id="phv00080778.v8.p11.c2" var_name="TISSUE_2" calculated_type="integer" reported_type=""><description>Tissue #2 related to Gleason score for prostate cancer</description><comment>Classifying prostate cancer cells in terms of how abnormal they appear when examined under a microscope. Grades range from 1 to 5 with 1 being the lease aggressive and 5 the most aggressive.
		This variable was added to the data collection form in version 10-01-07. </comment><total><subject_profile><sex><male>55</male></sex></subject_profile><stats><stat n="56" nulls="844" mean="3.321" sd="0.7887" median="3" min="1" max="5"/><enum count="31">3</enum><enum count="16">4</enum><enum count="4">5</enum><enum count="4">2</enum><enum count="1">1</enum></stats></total></variable><variable id="phv00080779.v8.p11" var_name="GLEASON" calculated_type="integer" reported_type=""><description>Gleason score: classifying prostate cancer cells</description><comment>Gleason score (total between 2-10) TISSUE_1 + TISSUE_2 = GLEASON If only GLEASON is given, TISSUE_1 and TISSUE_2 = "." If no scores are given, GLEASON = "." and TISSUE_1 and TISSUE_2 = "."
		This variable was added to the data collection form in version 10-01-07. </comment><total><subject_profile><sex><male>297</male></sex></subject_profile><stats><stat n="298" nulls="5036" mean="6.396" sd="1.35" median="6" min="2" max="10"/><enum count="121">6</enum><enum count="86">7</enum><enum count="33">8</enum><enum count="18">5</enum><enum count="14">9</enum><enum count="10">3</enum><enum count="10">4</enum><enum count="4">2</enum><enum count="2">10</enum></stats></total></variable><variable id="phv00080779.v8.p11.c1" var_name="GLEASON" calculated_type="integer" reported_type=""><description>Gleason score: classifying prostate cancer cells</description><comment>Gleason score (total between 2-10) TISSUE_1 + TISSUE_2 = GLEASON If only GLEASON is given, TISSUE_1 and TISSUE_2 = "." If no scores are given, GLEASON = "." and TISSUE_1 and TISSUE_2 = "."
		This variable was added to the data collection form in version 10-01-07. </comment><total><subject_profile><sex><male>235</male></sex></subject_profile><stats><stat n="235" nulls="4191" mean="6.43" sd="1.345" median="6" min="2" max="10"/><enum count="94">6</enum><enum count="72">7</enum><enum count="26">8</enum><enum count="12">5</enum><enum count="12">9</enum><enum count="7">3</enum><enum count="7">4</enum><enum count="4">2</enum><enum count="1">10</enum></stats></total></variable><variable id="phv00080779.v8.p11.c2" var_name="GLEASON" calculated_type="integer" reported_type=""><description>Gleason score: classifying prostate cancer cells</description><comment>Gleason score (total between 2-10) TISSUE_1 + TISSUE_2 = GLEASON If only GLEASON is given, TISSUE_1 and TISSUE_2 = "." If no scores are given, GLEASON = "." and TISSUE_1 and TISSUE_2 = "."
		This variable was added to the data collection form in version 10-01-07. </comment><total><subject_profile><sex><male>60</male></sex></subject_profile><stats><stat n="61" nulls="839" mean="6.262" sd="1.389" median="6" min="3" max="10"/><enum count="26">6</enum><enum count="13">7</enum><enum count="7">8</enum><enum count="6">5</enum><enum count="3">3</enum><enum count="3">4</enum><enum count="2">9</enum><enum count="1">10</enum></stats></total></variable><variable id="phv00159483.v7.p11" var_name="indicator" calculated_type="enum_integer" reported_type=""><description>Indicates ICD-O code book used for coding</description><total><subject_profile><sex><male>1996</male><female>2142</female></sex></subject_profile><stats><stat n="5334" nulls="0" mean_count="1778" sd="2921" median_count="153" min_count="31" max_count="5150"/><enum code="0" count="5150">ICD-O-1 code book</enum><enum code="1" count="153">ICD-O-3 code book</enum><enum code="2" count="31">ICD-O-3 code book using 'Coding Guidelines for Topography and Morphology' in front of code book</enum></stats></total></variable><variable id="phv00159483.v7.p11.c1" var_name="indicator" calculated_type="enum_integer" reported_type=""><description>Indicates ICD-O code book used for coding</description><total><subject_profile><sex><male>1680</male><female>1801</female></sex></subject_profile><stats><stat n="4426" nulls="0" mean_count="1475" sd="2422" median_count="126" min_count="28" max_count="4272"/><enum code="0" count="4272">ICD-O-1 code book</enum><enum code="1" count="126">ICD-O-3 code book</enum><enum code="2" count="28">ICD-O-3 code book using 'Coding Guidelines for Topography and Morphology' in front of code book</enum></stats></total></variable><variable id="phv00159483.v7.p11.c2" var_name="indicator" calculated_type="enum_integer" reported_type=""><description>Indicates ICD-O code book used for coding</description><total><subject_profile><sex><male>313</male><female>339</female></sex></subject_profile><stats><stat n="900" nulls="0" mean_count="300" sd="493.8" median_count="27" min_count="3" max_count="870"/><enum code="0" count="870">ICD-O-1 code book</enum><enum code="1" count="27">ICD-O-3 code book</enum><enum code="2" count="3">ICD-O-3 code book using 'Coding Guidelines for Topography and Morphology' in front of code book</enum></stats></total></variable><variable id="phv00080780.v8.p11" var_name="d_date" calculated_type="integer" units="days since exam 1" reported_type=""><description>Diagnosis date of tumor or cancer</description><comment>Date was taken from pathology reports if available. Date was taken from other records if pathology report was not available or if diagnosis was made before the biopsy then the variable EXACT = 1.
		If month and year were available, but not day, the 15th was used as the day, and the variable EXACT = 1. If only the year was available, JULY 4 was used as the month and day, and the variable EXACT = 1. 
		In some cases if biopsy was done at autopsy, then D_DATE was changed to precede DATE OF DEATH by one day. 
		D_DATE includes month, day and year, however this coding manual displays only month and year to preserve confidentiality. 
		Number of days since exam 1. </comment><total><subject_profile><sex><male>1996</male><female>2142</female></sex></subject_profile><stats><stat n="5334" nulls="0" mean="9120" sd="5311" median="9755" min="-10345" max="22506"/><example count="5">10713</example><example count="5">14245</example><example count="4">7092</example><example count="4">11584</example><example count="4">13121</example><example count="4">8437</example><example count="4">12207</example><example count="4">9405</example><example count="4">7234</example><example count="4">10327</example></stats></total></variable><variable id="phv00080780.v8.p11.c1" var_name="d_date" calculated_type="integer" units="days since exam 1" reported_type=""><description>Diagnosis date of tumor or cancer</description><comment>Date was taken from pathology reports if available. Date was taken from other records if pathology report was not available or if diagnosis was made before the biopsy then the variable EXACT = 1.
		If month and year were available, but not day, the 15th was used as the day, and the variable EXACT = 1. If only the year was available, JULY 4 was used as the month and day, and the variable EXACT = 1. 
		In some cases if biopsy was done at autopsy, then D_DATE was changed to precede DATE OF DEATH by one day. 
		D_DATE includes month, day and year, however this coding manual displays only month and year to preserve confidentiality. 
		Number of days since exam 1. </comment><total><subject_profile><sex><male>1680</male><female>1801</female></sex></subject_profile><stats><stat n="4426" nulls="0" mean="8770" sd="5342" median="9472" min="-10345" max="22506"/><example count="4">10713</example><example count="4">14245</example><example count="4">13121</example><example count="4">8437</example><example count="4">12207</example><example count="4">9405</example><example count="4">7234</example><example count="4">12677</example><example count="3">7092</example><example count="3">11174</example></stats></total></variable><variable id="phv00080780.v8.p11.c2" var_name="d_date" calculated_type="integer" units="days since exam 1" reported_type=""><description>Diagnosis date of tumor or cancer</description><comment>Date was taken from pathology reports if available. Date was taken from other records if pathology report was not available or if diagnosis was made before the biopsy then the variable EXACT = 1.
		If month and year were available, but not day, the 15th was used as the day, and the variable EXACT = 1. If only the year was available, JULY 4 was used as the month and day, and the variable EXACT = 1. 
		In some cases if biopsy was done at autopsy, then D_DATE was changed to precede DATE OF DEATH by one day. 
		D_DATE includes month, day and year, however this coding manual displays only month and year to preserve confidentiality. 
		Number of days since exam 1. </comment><total><subject_profile><sex><male>313</male><female>339</female></sex></subject_profile><stats><stat n="900" nulls="0" mean="10831" sd="4826" median="10695" min="-4465" max="21799"/><example count="3">11731</example><example count="3">20045</example><example count="2">14308</example><example count="2">12499</example><example count="2">15753</example><example count="2">10930</example><example count="2">21799</example><example count="2">11698</example><example count="2">11664</example><example count="2">19150</example></stats></total></variable></data_table>
